RESUMEN
Current treatment systems for tendon injuries are very few and do not ensure complete cure. This is a serious health concern for sports persons and the aged population. It is known that the nano- or microsized particles of natural products such as jeera/cumin seed (Cuminum cyminum) has been used traditionally as a home remedy for the treatment of tendon injuries. Nevertheless, these particles are likely to perform better due to their smaller size, increased absorption and local delivery in conjunction with nanotechnology. In this context, the major objective of this study was to synthesize silver-capped nanoparticles using aqueous extract of Cuminum cyminum (CCE) and to assess their in vitro non-cytotoxic effect with the perspective of clinical application to enhance tendon tissue regeneration. The presence of phytochemicals in CCE was studied by qualitative and quantitative methods. Cuminum cyminum nanoparticles (CCNP) were synthesized by the bioreduction method using silver nitrate and the particles were characterized by X-ray diffraction analysis (XRD), Fourier Transform Infra Red Spectroscopy (FTIR), Zeta potential measurement and scanning electron microscopy (SEM). The antioxidant effect of the particles was studied using total antioxidant activity and reducing power assay. Simultaneously, primary Tenocytes were isolated from rabbit Achilles tendon by collagenase and dispase digestion/treatment and characterized for Type 1 collagen. Further, in vitro non-cytotoxicity of the CCNP in direct contact with L929 mouse fibroblast cells and primary Tenocytes, respectively, was evaluated by MTT assay. Physico-chemical characterizations confirmed the formation and stability of the nanosize of CCNP with antioxidant property. Again, MTT assay confirmed the non-cytotoxicity of CCNP with L929 fibroblasts and primary Tenocytes. CCNP may be attributed as an ideal candidate for therapeutic application towards a faster restoration of worn-out/injured tendon tissue confronted by the geriatric and athlete communities.
Asunto(s)
Cuminum/química , Nanopartículas del Metal/química , Tenocitos/efectos de los fármacos , Animales , Antioxidantes/química , Antioxidantes/farmacología , Dispersión Dinámica de Luz , Fibroblastos/efectos de los fármacos , Tecnología Química Verde , Nanopartículas del Metal/uso terapéutico , Ratones , Extractos Vegetales/química , Conejos , Semillas/química , Plata , Tenocitos/fisiologíaRESUMEN
Ferrofluid-based manganese (Mn(2+)) substituted superparamagnetic iron oxide nanoparticles stabilized by surface coating with trisodium citrate (MnIOTCs) were synthesized for enhanced hyperthermic activity and use as negative magnetic resonance imaging (MRI) contrast media intended for applications in theranostics. The synthesized MnIOTC materials were characterized based on their physicochemical and biological features. The crystal size and the particle size at the nano level were studied using XRD and TEM. The presence of citrate molecules on the crystal surface of the iron oxide was established by FTIR, TGA, DLS and zeta potential measurements. The superparamagnetic property of MnIOTCs was measured using a vibrating sample magnetometer. Superparamagnetic iron oxide substituted with Mn(2+) with a 3:1 molar concentration of Mn(2+) to Fe(2+) and surface modified with trisodium citrate (MnIO75TC) that exhibited a high T2 relaxivity of 184.6mM(-1)s(-1) and showed excellent signal intensity variation in vitro. Hyperthermia via application of an alternating magnetic field to MnIO75TC in a HeLa cell population induced apoptosis, which was further confirmed by FACS and cLSM observations. The morphological features of the cells were highly disrupted after the hyperthermia experiment, as evidenced from E-SEM images. Biocompatibility evaluation was performed using an alamar blue assay and hemolysis studies, and the results indicated good cytocompatibility and hemocompatibility for the synthesized particles. In the current study, the potential of MnIO75TC as a negative MRI contrast agent and a hyperthermia agent was demonstrated to confirm its utility in the burgeoning field of theranostics.
Asunto(s)
Compuestos Férricos/administración & dosificación , Compuestos de Manganeso/administración & dosificación , Nanopartículas del Metal , Nanomedicina Teranóstica , Materiales Biocompatibles , Medios de Contraste , Hipertermia Inducida , Imagen por Resonancia MagnéticaRESUMEN
BACKGROUND: Pistacia lentiscus (Anacardiaceae) is a flowering plant traditionally used in the treatment of various skin, respiratory, and gastrointestinal disorders. The aim of this study was to assess whether Pistacia lentiscus oil has any short term toxic effects in vivo and in vitro. METHODS: Pistacia lentiscus oil (100µl) was administered orally into mice for 5 days. RESULTS: Measurements of body weight did not show any weight loss. Serum concentration of LDH did not show any significant statistical difference when compared to control mice. Similarly, blood, kidney or liver function tests showed no toxicity with Pistacia lentiscus oil when compared to the control group. Examination of gastrointestinal tissues sections revealed similar structural features with no difference in cell proliferation. In this context, pharmacological dilutions of Pistacia lentiscus oil (10(-6) - 10(-3)) did not affect the viability (cell death and proliferation) of mouse gastric stem cells, human colorectal cancer cells HT29, human hepatoma cells HepG2. However, it appears that at the dose and time point studied, Pistacia lentiscus oil treatment has targeted various cytochrome P450s and has specifically inhibited the activities and the expression of CYP2E1, CYP3A4, CYP1A1 and CYP1A2 differentially in different tissues. Our results also demonstrate that there is no appreciable effect of Pistacia lentiscus oil on the GSH-dependent redox homoeostasis and detoxification mechanism in the tissues. CONCLUSION: These data suggest a good safety profile of short term oral use of Pistacia lentiscus oil as a monotherapy in the treatment of various skin, respiratory, and gastrointestinal disorders. However, due to its inhibitory effect of various cytochrome P450s and mainly CYP3A4, this might have implications on the bioavailability and metabolism of drugs taken in combination with Pistacia lentiscus oil. More attention is needed when Pistacia lentiscus oil is intended to be uses in combination with other pharmacological agents in order to avoid potential drug-drug interaction leading to toxicity. This study will help in safer use of Pistacia lentiscus oil for therapeutic purpose.
Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Preparaciones Farmacéuticas/metabolismo , Pistacia/química , Aceites de Plantas/administración & dosificación , Aceites de Plantas/farmacología , Administración Oral , Animales , Línea Celular , Relación Dosis-Respuesta a Droga , Femenino , Frutas/química , Células HT29 , Células Hep G2 , Humanos , Ratones , Ratones Endogámicos , Especificidad de Órganos/efectos de los fármacos , Aceites de Plantas/química , Relación Estructura-ActividadRESUMEN
Hydroxyapatite (HA) ceramics are widely used as bone graft substitutes because of their biocompatibility and osteoconductivity. However, to enhance the success of therapeutic application, many efforts are undertaken to improve the bioactivity of HA. We have developed a triphasic, silica-containing ceramic-coated hydroxyapatite (HASi) and evaluated its performance as a scaffold for cell-based tissue engineering applications. Human bone marrow stromal cells (hBMSCs) were seeded on both HASi and HA scaffolds and cultured with and without osteogenic supplements for a period of 4 weeks. Cellular responses were determined in vitro in terms of cell adhesion, viability, proliferation, and osteogenic differentiation, where both materials exhibited excellent cytocompatibility. Nevertheless, an enhanced rate of cell proliferation and higher levels of both alkaline phosphatase expression and activity were observed for cells cultured on HASi with osteogenic supplements. These findings indicate that the bioactivity of HA endowed with a silica-containing coating has definitely influenced the cellular activity, projecting HASi as a suitable candidate material for bone regenerative therapy.
Asunto(s)
Células de la Médula Ósea/citología , Diferenciación Celular/efectos de los fármacos , Materiales Biocompatibles Revestidos/química , Durapatita/química , Osteogénesis , Células del Estroma/citología , Ingeniería de Tejidos/métodos , Adhesión Celular , Proliferación Celular , Supervivencia Celular , Humanos , Células Madre Mesenquimatosas/citología , Microscopía Confocal/métodos , Microscopía Electrónica de Rastreo/métodos , Dióxido de Silicio/químicaRESUMEN
Tea polyphenols, especially catechins, have been reported to be potent antioxidants and beneficial in oxidative stress-related diseases including cancer. Numerous animal and cell culture models demonstrate anticancer effects of tea catechins. Experimental and epidemiological evidence suggests the use of black tea polyphenols (BTP), green tea catechins (especially epigallocatechin gallate [EGCG]), and other polyphenols in preventing the progression of cancer both in animal and human populations. In the present study, we have demonstrated alterations in oxidative stress and redox metabolism using an isolated cell-free system and also in PC12 cancer cells after treatment with EGCG and BTP. We have demonstrated that tea catechins, alter the production of reactive oxygen species, glutathione metabolism, lipid peroxidation, and protein oxidation under in vitro conditions. We have also demonstrated that EGCG and BTP affect redox metabolism under cell culture conditions. Induction of apoptosis was observed, after the treatment with tea polyphenols, as shown by increased DNA breakdown and activation of the apoptotic markers, cytochrome c, caspase 3, and poly-(ADP-ribose) polymerase. These results may have implications in determining the chemopreventive and therapeutic use of tea catechins in vivo.
Asunto(s)
Apoptosis/efectos de los fármacos , Flavonoides/farmacología , Estrés Oxidativo , Fenoles/farmacología , Té/química , Animales , Western Blotting , Electroforesis en Gel de Poliacrilamida , Glutatión/metabolismo , Etiquetado Corte-Fin in Situ , Masculino , Oxidación-Reducción , Células PC12 , Polifenoles , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismoRESUMEN
In streptozotocin (STZ)-induced diabetes, destruction of pancreatic beta-cell causes an acute shortage of insulin. Increased oxidative stress is believed to be one of the main factors in the etiology and complications of diabetes. In this study we have reported hyperglycemia and glutathione-associated oxidative stress in rats one week after treatment with STZ. In our previous studies, we have reported oxidative stress-related changes in xenobiotic metabolism in tissues from STZ-induced chronic diabetic rats. Here, we demonstrate by immunohistochemistry, that glutathione S-transferase (GST) isoenzymes are differentially expressed in the liver, kidney and testis of diabetic rats. The distribution of GST isoenzymes was found to be tissue- and regio-specific. In addition, we have also shown that treatment with an extract of Momordica charantia (karela), an antidiabetic herb, modulates GST expression in diabetic rats and reverts them to the normal distribution as seen in the tissues of control rats. These results suggest that glutathione metabolism and GST distribution in the tissues of diabetic rats may play an important role in the etiology, pathology and prevention of diabetes.